Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4915-06-4 | MDL No. : | MFCD03410206 |
Formula : | C5H2BrNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VWVGOXGBMHAFFK-UHFFFAOYSA-N |
M.W : | 171.98 | Pubchem ID : | 708670 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 31.12 |
TPSA : | 36.93 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.89 cm/s |
Log Po/w (iLOGP) : | 1.63 |
Log Po/w (XLOGP3) : | 2.06 |
Log Po/w (WLOGP) : | 1.91 |
Log Po/w (MLOGP) : | 0.27 |
Log Po/w (SILICOS-IT) : | 1.95 |
Consensus Log Po/w : | 1.56 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.67 |
Solubility : | 0.371 mg/ml ; 0.00215 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.46 |
Solubility : | 0.59 mg/ml ; 0.00343 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.54 |
Solubility : | 0.491 mg/ml ; 0.00286 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.54 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With tert.-butylhydroperoxide; ammonium acetate; iodine; sodium carbonate In ethanol at 50℃; for 4.5 h; | In a 25 mL two-necked round bottom flask equipped with a thermometer and a magnetic stirrer4mmol5-bromofuran-2-carbaldehyde (1-18), 6 mmol of NH4OAc, 4 mmol of Na2CO3, 4.4 mmol of TBHP, 0.1 mmol of I2, 5 mL of absolute ethanol Solvent, and then the reaction flask was placed in an oil bath preheated to 50 ° C and opened with a magnetic stirrer for 4.5 h. reaction The solution was stirred by adding sodium thiosulfate solution and then extracted with ether. The organic layer was separated and the solvent was evaporated under reduced pressure. The elution was carried out with a mixture of ethyl acetate / petroleum ether in a volume ratio of 1: 100 as an eluent, and the eluate containing the target compound was collected And the solvent was evaporated to give 5-bromofuran-2-carbonitrile with an isolated yield of 85percent. |
82% | With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; sodium perchlorate; acetic acid; lithium hexamethyldisilazane In acetonitrile for 15 h; Electrochemical reaction | General procedure: Preparative electrolysis experiments were performed using 263 APotentiostat/Galvanostat (Princeton Applied Research, USA). 0.1 MNaClO4–CH3CN solution (10 mL) containing aldehydes (1 mmol),TEMPO (0.1 mmol), HMDS (2.5mmol) and AcOH (2.5mmol) was electrolyzedwith stirring in an undivided cell (30 mL) equipped with twoplatinum sheets as anode (1.5 cm2) and cathode (3.0 cm2) respectivelyat a constant potential of 1.5 V vs Ag/Ag+ (0.1MAgNO3 in acetonitrile).The electrode separation was 1 cm. When the reaction was finished,10mL of saturatedNa2SO3 solution was added into the reactionmixtureand stirred for 15 min. Then the mixture was extracted with CH2Cl2(20 mL × 3). The organic layer was dried with anhydrous Na2SO4 andconcentrated in a rotary evaporator. The productswere obtained via purificationof column chromatography and their structures were confirmedby 1H NMR, 13C NMR and MS. NMR was performed on a BrukerAvance III spectrometer. GC-MS was performed on the Thermo TraceISQ instrument with TG 5MS capillary column. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With [RhCl2(p-cymene)]2 In acetonitrile for 3 h; Reflux | To a solution of aldoxime 4 (2.90 g, 15.26mmol) in CH3CN(30 mL) were added [RuCl2(p-cymene)]2 (0.28g, 0.46mmol).The reaction mixture was refluxed for 3 h. After removal of solvent under reducedpressure, the residue was purified by silica gelchromatography with petroleum ether/EtOAc (5:1) to afford 5 as a colorless oil (1.84 g, 70percent).1H NMR (300 MHz, CDCl3) δ 7.06 (1H, d, J = 3 Hz), 6.48 (1H, d, J= 3 Hz). |
[ 585-70-6 ]
5-Bromofuran-2-carboxylic acid
Similarity: 0.58
[ 2527-99-3 ]
Methyl 5-bromofuran-2-carboxylate
Similarity: 0.55
[ 212197-74-5 ]
5-Cyanofuran-2-carboxylic acid
Similarity: 0.52
[ 118449-57-3 ]
3-(4-Bromophenoxy)propanenitrile
Similarity: 0.51
[ 31518-13-5 ]
3,4-Dihydro-2H-pyran-6-carbonitrile
Similarity: 0.50
[ 585-70-6 ]
5-Bromofuran-2-carboxylic acid
Similarity: 0.58